Research graph
References from Crosstalk between visceral adipose tissue secretome and tumoral microenvironment in obesity-induced colorectal cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
General insight into cancer: an overview of colorectal cancer (review)
10.3892/mco.2021.2433 · 2021 · External reference
Colorectal cancer: from risk factors to oncogenesis
10.3390/medicina59091646 · 2023 · External reference
Association between a body shape index and colorectal cancer in US population: a cross-sectional study based on NHANES
2025 · External reference
Analysis of the burden of colorectal cancer attributable to high body mass index in 204 countries and regions worldwide from 1990 to 2021
2025 · External reference
The global, regional, and national burden of colorectal cancer in 204 countries and territories from 1990 to 2019
10.1007/s10389-023-01831-6 · 2024 · External reference
Obesity-associated colorectal cancer
10.3390/ijms25168836 · 2024 · External reference
The global burden of colorectal cancer attributable to high body-mass index in 204 countries and territories: findings from 1990 to 2021 and predictions to 2035
10.3389/fnut.2024.1473851 · 2024 · External reference
Worldwide burden and cross-regional health inequalities of high BMI-attributable colorectal cancer by gender from 1990 to 2021, with predictions through 2041
10.1186/s12876-025-03938-4 · 2025 · External reference
The risk of colorectal cancer according to obesity status at four-year intervals: a nationwide population-based cohort study
10.1038/s41598-023-36111-6 · 2023 · External reference
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: a spotlight on the contribution of the endosome-lysosome system
10.1016/j.canlet.2024.216639 · 2024 · External reference
Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: evidence from the National Health and Nutrition Examination Survey 2001–2018
10.1371/journal.pone.0290994 · 2023 · External reference
Advantages and limitations of the body mass index (BMI) to assess adult obesity
10.3390/ijerph21060757 · 2024 · External reference
Review article: obesity and colorectal cancer
10.1111/apt.17045 · 2022 · External reference
Obesity and colorectal cancer: a narrative review
10.3390/medicina60081218 · 2024 · External reference
Overweight as an avoidable cause of cancer in Europe
10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t · 2001 · External reference
A review article: the relationship between obesity and colorectal cancer
10.1007/s11892-024-01556-0 · 2025 · External reference
Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management
10.3390/cancers15020485 · 2023 · External reference
Obesity and cancer risk: Emerging biological mechanisms and perspectives
10.1016/j.metabol.2018.11.001 · 2019 · External reference
Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms
10.1002/1878-0261.12772 · 2021 · External reference
To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?
10.1002/cac2.12659 · 2025 · External reference
Unresolved reference
External reference
Insights behind the relationship between colorectal cancer and obesity: is visceral adipose tissue the missing link?
10.3390/ijms232113128 · 2022 · External reference
Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis
10.1007/s10238-024-01505-x · 2024 · External reference
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
10.1038/s41467-021-25333-9 · 2021 · External reference
The role of adipocytes recruited as part of tumor microenvironment in promoting colorectal cancer metastases
2024 · External reference
The role of adipogenic niche resident cells in colorectal cancer progression in relation to obesity
10.1111/obr.13873 · 2025 · External reference
White adipose tissue dysfunction in obesity and aging
10.1016/j.bcp.2021.114723 · 2021 · External reference
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
10.3390/ijms20092358 · 2019 · External reference
Exploring visceral and subcutaneous adipose tissue secretomes in human obesity: implications for metabolic disease
10.1210/endocr/bqac140 · 2022 · External reference
Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease
10.3389/fcvm.2020.00022 · 2020 · External reference
The pathophysiology of visceral adipose tissues in cardiometabolic diseases
10.1016/j.bcp.2024.116116 · 2024 · External reference
Metabolic differences between subcutaneous and visceral adipocytes differentiated with an excess of saturated and monounsaturated fatty acids
10.3390/genes11091092 · 2020 · External reference
Excess body weight: Novel insights into its roles in obesity comorbidities
10.1016/j.semcancer.2023.03.008 · 2023 · External reference
Innate lymphocytes in adipose tissue homeostasis and their alterations in obesity and colorectal cancer
10.3389/fimmu.2018.02556 · 2018 · External reference
Metabolomics of abdominal adipose tissue samples collected from patients with obesity – a critical review
10.1007/s11010-025-05399-5 · 2025 · External reference
Linking obesity with colorectal cancer: epidemiology and mechanistic insights
10.3390/cancers12061408 · 2020 · External reference
Association between adiposity distribution and high-sensitivity C-reactive protein, adipokines, interleukins and plasminogen activator inhibitor-1
10.1038/s41366-025-01816-3 · 2025 · External reference
Correlation of the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, inflammatory markers, and tumor markers with the diagnosis and prognosis of colorectal cancer
2023 · External reference
Adipose tissue inflammation and metabolic dysfunction in obesity
10.1152/ajpcell.00379.2020 · 2021 · External reference
Adipose tissue expansion in obesity, health, and disease
10.3389/fcell.2023.1188844 · 2023 · External reference
Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity—The Case of BBS Obesity
10.3390/nu15153445 · 2023 · External reference
Adipokines mediate inflammation and insulin resistance
10.3389/fendo.2013.00071 · 2013 · External reference
The regulation of adipocyte growth in white adipose tissue
10.3389/fcell.2022.1003219 · 2022 · External reference
Targeting the vasculature in cardiometabolic disease
10.1172/jci148556 · 2022 · External reference
Hypoxia in human obesity: new insights from inflammation towards insulin resistance—a narrative review
10.3390/ijms25189802 · 2024 · External reference
Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells
10.3389/fphys.2020.624903 · 2021 · External reference
Key roles of brown, subcutaneous, and visceral adipose tissues in obesity and insulin resistance
10.3390/cimb47050343 · 2025 · External reference
Endoplasmic reticulum stress: bridging inflammation and obesity-associated adipose tissue
2024 · External reference
The role of adipocyte endoplasmic reticulum stress in obese adipose tissue dysfunction: a review
10.2147/ijgm.s428482 · 2023 · External reference
Obese visceral fat tissue inflammation: from protective to detrimental?
10.1186/s12916-022-02672-y · 2022 · External reference
Adipose tissue, immune aging, and cellular senescence
10.1007/s00281-020-00812-1 · 2020 · External reference
The impact of cellular senescence in human adipose tissue
10.1007/s12079-023-00769-4 · 2023 · External reference
White adipocyte dysfunction and obesity-associated pathologies in humans
10.1038/s41580-023-00680-1 · 2024 · External reference
The mechanisms of chronic inflammation in obesity and potential therapeutic strategies: a narrative review
10.3390/cimb47050357 · 2025 · External reference
Ceramides and Sphingosino-1-Phosphate in Obesity
10.3389/fendo.2021.635995 · 2021 · External reference
Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
10.3389/fimmu.2020.576347 · 2020 · External reference
Regulation of cholesterol storage in adipose tissue
10.1016/s0022-2275(20)36769-9 · 1974 · External reference
Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover
10.1172/jci108028 · 1975 · External reference
Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study
10.1016/s0022-2275(20)32337-3 · 2001 · External reference
De Novo Synthesis of Steroids and Oxysterols in Adipocytes
10.1074/jbc.m113.534172 · 2014 · External reference
Association of Cholesterol and Oxysterols in Adipose Tissue With Obesity and Metabolic Syndrome Traits
10.1210/clinem/dgac188 · 2022 · External reference
27-hydroxycholesterol is a regulatory oxysterol in adipocytes
2026 · External reference
Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer?
10.4103/sjg.sjg_44_21 · 2022 · External reference
Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice
10.1007/s00125-013-2885-1 · 2013 · External reference
The role of JNK signaling pathway in obesity-driven insulin resistance
10.2147/dmso.s236127 · 2020 · External reference
Adipose tissue dysfunction: impact on metabolic changes?
10.1055/a-1922-7052 · 2022 · External reference
JNK at the crossroad of obesity, insulin resistance, and cell stress response
10.1016/j.molmet.2016.12.001 · 2017 · External reference
Role of innate and adaptive immunity in obesity-associated metabolic disease
10.1172/jci88876 · 2017 · External reference
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
10.1038/cmi.2009.43 · 2009 · External reference
Obesity-induced TNFα and IL-6 signaling: the missing link between obesity and inflammation—driven liver and colorectal cancers
10.3390/cancers11010024 · 2018 · External reference
Inflammasome: structure, biological functions, and therapeutic targets
10.1002/mco2.391 · 2023 · External reference
NLRP3 inflammasome: a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development
10.3389/fimmu.2018.02918 · 2018 · External reference
Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells
10.1172/jci126078 · 2020 · External reference
NOD-like receptors—emerging links to obesity and associated morbidities
10.3390/ijms24108595 · 2023 · External reference
Role of NLRP3 inflammasome activation in obesity-mediated metabolic disorders
10.3390/ijerph18020511 · 2021 · External reference
NLRP3 inflammasome activation in adipose tissues and its implications on metabolic diseases
2020 · External reference
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
10.1016/j.cmet.2010.11.011 · 2010 · External reference
Mechanisms of Inflammatory Responses in Obese Adipose Tissue
10.1146/annurev-nutr-071811-150623 · 2012 · External reference
Innate Immune System Orchestrates Metabolic Homeostasis and Dysfunction in Visceral Adipose Tissue During Obesity
10.3389/fimmu.2021.702835 · 2021 · External reference
Adipocytes and macrophages interplay in the orchestration of tumor microenvironment: new implications in cancer progression
10.3389/fimmu.2017.01129 · 2017 · External reference
Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines
2013 · External reference
Macrophage polarization mediated by mitochondrial dysfunction induces adipose tissue inflammation in obesity
2022 · External reference
New insights into adipose tissue macrophages in obesity and insulin resistance
10.3390/cells11091424 · 2022 · External reference
Inflammation and resolution in obesity
10.1038/s41574-024-01047-y · 2025 · External reference
Regulatory mechanisms of macrophage polarization in adipose tissue
10.3389/fimmu.2023.1149366 · 2023 · External reference
Unraveling the complex roles of macrophages in obese adipose tissue: an overview
10.1007/s11684-023-1033-7 · 2024 · External reference
T cells in health and disease
10.1038/s41392-023-01471-y · 2023 · External reference
Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives
10.1038/s41420-025-02403-1 · 2025 · External reference
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
10.3390/ijms15046184 · 2014 · External reference
Obesity: modulating adiponectin levels through diet
2018 · External reference
The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction
2016 · External reference
Pathophysiology of obesity and its associated diseases
10.1016/j.apsb.2023.01.012 · 2023 · External reference
Leptin and obesity: role and clinical implication
10.3389/fendo.2021.585887 · 2021 · External reference
Adipokines and bacterial metabolites: a pivotal molecular bridge linking obesity and gut microbiota dysbiosis to target
10.3390/biom13121692 · 2023 · External reference
Putative positive role of inflammatory genes in fat deposition supported by altered gene expression in purified human adipocytes and preadipocytes from lean and obese adipose tissues
10.1186/s12967-020-02611-6 · 2020 · External reference
Immunological roles for resistin and related adipokines in obesity-associated tumors
10.1016/j.intimp.2024.112911 · 2024 · External reference
The role of adipokines in health and disease
10.3390/biomedicines11051290 · 2023 · External reference
Increased expression levels of Netrin-1 in visceral adipose tissue during obesity favour colon cancer cell migration
10.3390/cancers15041038 · 2023 · External reference
Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer
10.1007/s00109-025-02546-9 · 2025 · External reference
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis
10.1172/jci88883 · 2017 · External reference
Nutrition and cellular senescence in obesity-related disorders
10.1016/j.jnutbio.2021.108861 · 2022 · External reference
Increased cell senescence in human metabolic disorders
10.1172/jci169922 · 2023 · External reference
Association of Adipokines and Insulin, Which Have a Role in Obesity, with Colorectal Cancer
10.5152/eurasianjmed.2018.18089 · 2019 · External reference
Regulators of TNFα mediated insulin resistance elucidated by quantitative proteomics
10.1038/s41598-020-77914-1 · 2020 · External reference
From gut microbiota through low-grade inflammation to obesity: key players and potential targets
10.3390/nu14102103 · 2022 · External reference
Gut microbiota and adipose tissue microenvironment interactions in obesity
10.3390/metabo13070821 · 2023 · External reference
Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases
2022 · External reference
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
10.1038/s41575-023-00867-z · 2024 · External reference
Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans
10.1016/j.cell.2020.09.009 · 2020 · External reference
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
10.3389/fcimb.2021.744606 · 2021 · External reference
Weighty matters: Unraveling the impact of obesity on colorectal cancer and nutritional interventions
10.1016/j.semcancer.2025.06.004 · 2025 · External reference
Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved
10.1007/s11739-023-03262-3 · 2023 · External reference
High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway
2012 · External reference
Signaling Modifications Associated with Obesity and Dysbiosis and Their Impact on Metabolic Disorders
10.33696/signaling.5.113 · 2024 · External reference
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
10.1016/j.chom.2022.02.004 · 2022 · External reference
Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer
10.1002/advs.202205563 · 2023 · External reference
Butyrate blocks cell cycle progression in colorectal cancer organoids partially through HDAC2 inhibition
2026 · External reference
Implication of obesity and gut microbiome dysbiosis in the etiology of colorectal cancer
10.3390/cancers15061913 · 2023 · External reference
Visceral adipose tissue mesenchymal stromal cells in the intersection of immunology and metabolism
10.1152/ajpendo.00341.2020 · 2021 · External reference
Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link
2025 · External reference
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia
10.1038/s41419-025-07982-6 · 2025 · External reference
Characteristics of the colorectal cancer microenvironment—role in cancer progression and therapeutic possibilities
10.3390/app14072930 · 2024 · External reference
Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses
2022 · External reference
Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression
10.1186/s12967-022-03661-8 · 2022 · External reference
The cytokine network in colorectal cancer: implications for new treatment strategies
10.3390/cells12010138 · 2022 · External reference
Tumor microenvironment signaling and therapeutics in cancer progression
10.1002/cac2.12416 · 2023 · External reference
Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs
2023 · External reference
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
10.3389/fimmu.2024.1353787 · 2024 · External reference
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis
10.1038/s41598-020-67842-5 · 2020 · External reference
The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment
10.1111/cas.15609 · 2023 · External reference
IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer
10.1038/s41467-023-39953-w · 2023 · External reference
Morphological and functional changes in the peritumoral adipose tissue of colorectal cancer patients
10.1002/oby.22008 · 2017 · External reference
Peritumoural adipose tissue drives immune evasion in colorectal cancer via adipose–mesenchymal transformation
10.1038/s41556-026-01885-0 · 2026 · External reference
Molecular mechanisms of tumor immunomodulation in the microenvironment of colorectal cancer
10.3390/ijms23052782 · 2022 · External reference
Therapeutic targets and tumor microenvironment in colorectal cancer
10.3390/jcm10112295 · 2021 · External reference
Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
10.3389/fimmu.2022.984480 · 2022 · External reference
The role of the tumor microenvironment and treatment strategies in colorectal cancer
10.3389/fimmu.2021.792691 · 2021 · External reference
T cells in colorectal cancer: unravelling the function of different T cell subsets in the tumor microenvironment
2023 · External reference
The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells
2025 · External reference
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
10.3389/fimmu.2020.01052 · 2020 · External reference
Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids
10.3389/fimmu.2023.1105244 · 2023 · External reference
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
10.3389/fimmu.2021.724883 · 2021 · External reference
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
10.1038/s41392-025-02280-1 · 2025 · External reference
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies
10.3389/fimmu.2025.1548234 · 2025 · External reference
Towards a consensus definition of immune exclusion in cancer
10.3389/fimmu.2023.1084887 · 2023 · External reference
In vitro 3D modeling of colorectal cancer: the pivotal role of the extracellular matrix, stroma and immune modulation
10.3389/fgene.2025.1545017 · 2025 · External reference
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
10.1186/s12943-024-02208-3 · 2025 · External reference
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
10.3389/fonc.2021.668349 · 2021 · External reference
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
10.1186/s12943-023-01899-4 · 2023 · External reference
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression
10.1038/s41467-024-54920-9 · 2024 · External reference
The roles of matrix metalloproteinases and their inhibitors in human diseases
10.3390/ijms21249739 · 2020 · External reference
Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver
10.1038/s12276-026-01650-1 · 2026 · External reference
Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer
10.1038/cddis.2017.21 · 2017 · External reference
Host and microbiome lipid metabolism in colorectal cancer development and therapy
10.1016/j.trecan.2025.08.005 · 2025 · External reference
Exosome-derived miRNAs regulate macrophage-colorectal cancer cell cross-talk during aggressive tumor development
10.2217/crc-2022-0012 · 2023 · External reference
Dietary fatty acids at the crossroad between obesity and colorectal cancer: fine regulators of adipose tissue homeostasis and immune response
10.3390/cells10071738 · 2021 · External reference
Multi-faceted role of cancer-associated adipocytes in colorectal cancer
10.3390/biomedicines11092401 · 2023 · External reference
An Updated Review of Resistin and Colorectal Cancer
10.7759/cureus.65403 · 2024 · External reference
Crosstalk between leptin and adiponectin in colorectal cancer: molecular mechanisms and oncogenic pathways
10.3390/ijms27041789 · 2026 · External reference
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives
10.1038/s41392-025-02249-0 · 2025 · External reference
Progress in understanding the IL-6/STAT3 pathway in colorectal cancer
10.2147/ott.s278013 · 2020 · External reference
A systematic review on leptin’s role in defining cancer: special emphasis on immunomodulation, inflammation, and therapeutic interventions
10.1038/s41435-025-00333-7 · 2025 · External reference
MicroRNAs and angiogenesis: a new era for the management of colorectal cancer
10.1186/s12935-021-01920-0 · 2021 · External reference
Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression
10.1007/s12032-023-02099-2 · 2023 · External reference
Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
10.3389/fonc.2022.911856 · 2022 · External reference
Synthesis and regulation of miRNA, its role in oncogenesis, and its association with colorectal cancer progression, diagnosis, and prognosis
10.3390/diagnostics14131450 · 2024 · External reference
Integrated transcriptome analysis of human visceral adipocytes unravels dysregulated microRNA-long non-coding RNA-mRNA networks in obesity and colorectal cancer
10.3389/fonc.2020.01089 · 2020 · External reference
Elucidation of molecular links between obesity and cancer through microRNA regulation
2020 · External reference
Advances in microRNAs as emerging biomarkers for colorectal cancer early detection and diagnosis
10.3390/ijms252011060 · 2024 · External reference
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
10.1016/j.omtn.2020.03.003 · 2020 · External reference
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
10.1016/j.phrs.2022.106568 · 2023 · External reference
The role of miR-155 in antitumor immunity
10.3390/cancers14215414 · 2022 · External reference
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
10.1007/s40291-023-00641-6 · 2023 · External reference
The role of miR-16 and miR-34a family in the regulation of cancers: A review
10.1016/j.heliyon.2025.e42733 · 2025 · External reference
MicroRNA-34 family in cancers: role, mechanism, and therapeutic potential
10.3390/cancers15194723 · 2023 · External reference
miR-34: from bench to bedside
10.18632/oncotarget.1825 · 2014 · External reference
The role of miR-200 family in the regulation of hallmarks of cancer
10.3389/fonc.2022.965231 · 2022 · External reference
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
10.1038/onc.2012.266 · 2013 · External reference
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
10.1186/s12935-015-0247-4 · 2015 · External reference
Prognostic roles of microRNA 143 and microRNA 145 in colorectal cancer: A meta-analysis
10.1177/1724600818807492 · 2019 · External reference
miR-145 improves metabolic inflammatory disease through multiple pathways
10.1093/jmcb/mjz015 · 2020 · External reference
Obesity alters the microRNA expression profile related to metabolic disorders in peripheral blood mononuclear cells: preliminary results
10.3390/cimb47100799 · 2025 · External reference
Tumor biomarkers for diagnosis, prognosis and targeted therapy
10.1038/s41392-024-01823-2 · 2024 · External reference
Phases of Biomarker Development for Early Detection of Cancer
10.1093/jnci/93.14.1054 · 2001 · External reference
Biomarkers of inflammation and colorectal cancer risk
2025 · External reference
Assessment of Adipokine and Inflammation Biomarkers with Cancer Risk among Chinese Men: A Prospective Cohort Study
10.1158/1055-9965.epi-25-0342 · 2025 · External reference
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
10.1210/endrev/bnad005 · 2023 · External reference
C-reactive protein – My perspective on its first half century, 1930-1982
10.3389/fimmu.2023.1150103 · 2023 · External reference
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
10.1084/jem.52.4.561 · 1930 · External reference
Associations of Circulating Inflammatory Biomarkers with Risk Factors for Colorectal Cancer in Colorectal Adenoma Patients
10.4137/bmi.s10092 · 2012 · External reference
Prospective changes in lipocalin-2 and adipocytokines among adults with obesity
10.1038/s41598-025-14091-z · 2025 · External reference
Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort
10.1002/ijc.35205 · 2025 · External reference
Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC–Potsdam Cohort Study
10.1158/0008-5472.can-15-3464 · 2016 · External reference
The role of omentin-1 in cancers development and progression
10.3390/cancers15153797 · 2023 · External reference
Biological multi-omics approaches to next-generation biomarkers in immune-related disorders and malignancies: an overview
10.1007/s12094-025-04128-0 · 2025 · External reference
Multiomics strategy-based obesity biomarkers discovery for precision medicine
2025 · External reference
Genome-wide analysis reveals DNA methylation alterations in obesity associated with high risk of colorectal cancer
2019 · External reference
Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis
10.1371/journal.pone.0268436 · 2022 · External reference
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection
10.1038/s41698-024-00732-5 · 2024 · External reference
A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case–Control Studies
10.3390/metabo13020234 · 2023 · External reference
Gut microbiota and metabolome signatures in obese and normal-weight patients with colorectal tumors
10.1016/j.isci.2025.112221 · 2025 · External reference
Mendelian randomization unraveled: gender-specific insights into obesity-related phenotypes and colorectal cancer susceptibility
2024 · External reference
Integrating multi-omics summary data using a Mendelian randomization framework
10.1093/bib/bbac376 · 2022 · External reference
Revealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis
10.3389/fcimb.2024.1452392 · 2024 · External reference
Shared plasma metabolites mediate causal effects of metabolic diseases on colorectal cancer: a two-step Mendelian randomization study
10.3390/biomedicines13102433 · 2025 · External reference
Prognostic value and clinicopathological significance of pre-and post-treatment systemic immune-inflammation index in colorectal cancer patients: a meta-analysis
10.1186/s12957-025-03662-z · 2025 · External reference
Systemic inflammation response index as a prognostic marker in cancer patients: a systematic review and meta-analysis of 38 cohorts
10.1177/15593258211064744 · 2021 · External reference
The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
10.1007/s12094-022-02861-4 · 2022 · External reference
Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation
10.1016/j.celrep.2024.114516 · 2024 · External reference
Association between the triglyceride-glucose index (TyG index) and risk of colorectal cancer: a systematic review and meta-analysis
10.1186/s12957-025-03930-y · 2025 · External reference
Temporal relationship between chronic inflammation and insulin resistance and their combined cumulative effect on cancer risk: a longitudinal cohort study
10.1186/s12889-025-22632-4 · 2025 · External reference
Secondary bile acids and tumorigenesis in colorectal cancer
2022 · External reference
Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case–control study in the European Prospective Investigation into Cancer and Nutrition (EPIC)
10.1016/j.ebiom.2024.105024 · 2024 · External reference
Fusobacterium nucleatum: pathophysiological and clinical involvement in inflammatory bowel diseases, colorectal cancer and cardiovascular diseases
10.3390/cancers17203348 · 2025 · External reference
Fusobacterium nucleatum and colorectal cancer: from phenomenon to mechanism
10.3389/fcimb.2022.1020583 · 2022 · External reference
Systematic review: the gut microbiota as a link between colorectal cancer and obesity
10.1111/obr.13872 · 2025 · External reference
Novel genetic association between obesity, colorectal cancer, and inflammatory bowel disease
10.1007/s40200-023-01343-w · 2023 · External reference
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
2025 · External reference
A Liquid Biopsy-Based Approach to Isolate and Characterize Adipose Tissue-Derived Extracellular Vesicles from Blood
10.1021/acsnano.3c00422 · 2023 · External reference
Prognostic significance of circulating tumor DNA in non-metastatic colorectal cancer
2025 · External reference
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring
10.1186/s12943-024-02063-2 · 2024 · External reference
Clinical utility and future perspectives of liquid biopsy in colorectal cancer
10.1038/s43856-025-00852-4 · 2025 · External reference
Circulating tumor DNA as a minimal residual disease assessment and recurrence risk in patients undergoing curative-intent resection with or without adjuvant chemotherapy in colorectal cancer: a systematic review and meta-analysis
10.3390/ijms241210230 · 2023 · External reference
Effect of visceral fat area on the accuracy of preoperative CT-N staging of colorectal cancer
10.1016/j.ejrad.2023.111131 · 2023 · External reference
Liquid biopsy for colorectal cancer: advancing detection and clinical application
10.3390/ijtm5020014 · 2025 · External reference
Preoperative inflammatory markers as a predictor of three-year overall survival in older cancer patients undergoing oncologic surgery
10.3390/cancers13081824 · 2021 · External reference
Obesity, insulin resistance, and colorectal cancer: could miRNA dysregulation play a role?
10.3390/ijms20122922 · 2019 · External reference
The role of circulating tumor cells as a liquid biopsy for cancer: advances, biology, technical challenges, and clinical relevance
10.3390/cancers16071377 · 2024 · External reference
Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis
10.1186/s12943-025-02465-w · 2025 · External reference
Flow cytometry in the detection of circulating tumor cells in neoplastic effusions
10.1016/j.cca.2023.117651 · 2024 · External reference
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
10.1016/j.apsb.2022.01.002 · 2022 · External reference
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
10.1016/j.cmet.2015.02.006 · 2015 · External reference
Understanding the interplay between obesity and cancer: from mechanisms to therapeutic opportunities
10.3390/cancers18101620 · 2026 · External reference
Inflammasome components as new therapeutic targets in inflammatory disease
10.1038/s41577-024-01075-9 · 2025 · External reference
The many facets of PPAR-γ agonism in obesity and associated comorbidities: benefits, risks, challenges, and future directions
10.1007/s13679-025-00612-4 · 2025 · External reference
Inhibition of PPARγ by natural compounds as a promising strategy in obesity and diabetes
10.2174/1874104501913010007 · 2019 · External reference
Structure-based discovery of a novel nuclear receptor PPARγ inhibitor: Implications for obesity and metabolic disease intervention
10.1016/j.biopha.2025.118615 · 2025 · External reference
The Influence of GLP-1 Receptor Agonists on Five-Year Mortality in Colon Cancer Patients
10.1080/07357907.2025.2585512 · 2025 · External reference
GLP-1 receptor agonists and the risk for cancer: a meta-analysis of randomized controlled trials
10.1111/dom.16489 · 2025 · External reference
Metabolic modulation in cancer care: the potential role of glucagon-like peptide-1 receptor agonists
10.1200/jco-26-00062 · 2026 · External reference
Improving analysis of sexual dimorphism in body composition dynamics in the oncology setting: a scoping review
10.1016/j.clnesp.2025.03.169 · 2025 · External reference
Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review
10.1158/1940-6207.capr-20-0633 · 2021 · External reference
Metabolic phenotypes and risk of colorectal cancer: a systematic review and meta-analysis of cohort studies
10.1186/s12885-021-09149-w · 2022 · External reference
Metabolically healthy obesity and metabolically obese normal weight: a review
10.1007/s13105-020-00781-x · 2021 · External reference
